Increased neuronal Rab5 immunoreactive endosomes do not colocalize with TDP-43 in motor neuron disease

Experimental Neurology

Volumn 225, Issue 1, 2010, Pages 133-139

  Matej, Radoslav ^a,b   Botond, Gergö ^a   László, Lajos ^c   Kopitar Jerala, Natasa ^d   Rusina, Robert ^e   Budka, Herbert ^a   Kovacs, Gabor G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d JO EF STEFAN INSTITUTE   (Slovenia)

^e Thomayer Teaching Hospital and Institute for Postgraduate Education in Medicine   (Czech Republic)

Author keywords

Cathepsin; Endosome; Lysosome; Motor neuron disease; Rab5; TDP 43; Ubiquitin

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CATHEPSIN F; CATHEPSIN L; PROTEIN P62; RAB PROTEIN; TAR DNA BINDING PROTEIN; UBIQUITIN; DNA BINDING PROTEIN; PROTEIN TDP-43;

ADULT; AGED; ANTERIOR HORN CELL; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSOME; HUMAN; HUMAN TISSUE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MORPHOMETRICS; MOTONEURON; MOTOR NEURON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ACTIVE TRANSPORT; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENETICS; INTRACELLULAR FLUID; LYSOSOME; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT; ULTRASTRUCTURE;

ACTIVE TRANSPORT, CELL NUCLEUS; AGED; DNA-BINDING PROTEINS; ENDOSOMES; FEMALE; HUMANS; INTRACELLULAR FLUID; LYSOSOMES; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; PHOSPHORYLATION; PROTEIN TRANSPORT; RAB5 GTP-BINDING PROTEINS;

EID: 77955661185     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.06.004     Document Type: Article

References (39)

1. Ayala Y.M., Zago P., D'Ambrogio A., Xu Y.F., Petrucelli L., Buratti E., Baralle F.E. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008, 121:3778-3785.
2. Benajiba L., Le Ber I., Camuzat A., Lacoste M., Thomas-Anterion C., Couratier P., Legallic S., Salachas F., Hannequin D., Decousus M., Lacomblez L., Guedj E., Golfier V., Camu W., Dubois B., Campion D., Meininger V., Brice A. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann. Neurol. 2009, 65:470-473.
3. Cairns N.J., Neumann M., Bigio E.H., Holm I.E., Troost D., Hatanpaa K.J., Foong C., White C.L., Schneider J.A., Kretzschmar H.A., Carter D., Taylor-Reinwald L., Paulsmeyer K., Strider J., Gitcho M., Goate A.M., Morris J.C., Mishra M., Kwong L.K., Stieber A., Xu Y., Forman M.S., Trojanowski J.Q., Lee V.M., Mackenzie I.R. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 2007, 171:227-240.
4. Chu C.T., Plowey E.D., Wang Y., Patel V., Jordan-Sciutto K.L. Location, location, location: altered transcription factor trafficking in neurodegeneration. J. Neuropathol. Exp. Neurol. 2007, 66:873-883.
5. Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009, 111:1051-1061.
6. Conus S., Simon H.U. Cathepsins: key modulators of cell death and inflammatory responses. Biochem. Pharmacol. 2008, 76:1374-1382.
7. Filimonenko M., Stuffers S., Raiborg C., Yamamoto A., Malerod L., Fisher E.M., Isaacs A., Brech A., Stenmark H., Simonsen A. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 2007, 179:485-500.
8. Geser F., Martinez-Lage M., Robinson J., Uryu K., Neumann M., Brandmeir N.J., Xie S.X., Kwong L.K., Elman L., McCluskey L., Clark C.M., Malunda J., Miller B.L., Zimmerman E.A., Qian J., Van Deerlin V., Grossman M., Lee V.M., Trojanowski J.Q. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch. Neurol. 2009, 66:180-189.
9. Giordana M.T., Piccinini M., Grifoni S., De Marco G., Vercellino M., Magistrello M., Pellerino A., Buccinna B., Lupino E., Rinaudo M.T. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 2010, 20:351-360.
10. Hacker G.W., Muss W.H., Hauser-Kronberger C., Danscher G., Rufner R., Gu J., Su H., Andreasen A., Stoltenberg M., Dietze O. Electron microscopical autometallography: immunogold-silver staining (IGSS) and heavy-metal histochemistry. Methods 1996, 10:257-269.
11. Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., Nakano I., Oda T., Tsuchiya K., Akiyama H. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008, 64:60-70.
12. Jacquier A., Buhler E., Schafer M.K., Bohl D., Blanchard S., Beclin C., Haase G. Alsin/Rac1 signaling controls survival and growth of spinal motoneurons. Ann. Neurol. 2006, 60:105-117.
13. Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D. TDP-43 is intrinsically aggregation-prone and ALS-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009, 284:20329-20339.
14. Kato S. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol. 2008, 115:97-114.
15. Kikuchi H., Yamada T., Furuya H., Doh-ura K., Ohyagi Y., Iwaki T., Kira J. Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis. Acta Neuropathol. 2003, 105:462-468.
16. Kovacs G.G., Gelpi E., Strobel T., Ricken G., Nyengaard J.R., Bernheimer H., Budka H. Involvement of the endosomal-lysosomal system correlates with regional pathology in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 2007, 66:628-636.
17. Kuester D., Lippert H., Roessner A., Krueger S. The cathepsin family and their role in colorectal cancer. Pathol. Res. Pract. 2008, 204:491-500.
18. Kunita R., Otomo A., Mizumura H., Suzuki-Utsunomiya K., Hadano S., Ikeda J.E. The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis. J. Biol. Chem. 2007, 282:16599-16611.
19. Lin W.L., Dickson D.W. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 2008, 116:205-213.
20. Miaczynska M., Christoforidis S., Giner A., Shevchenko A., Uttenweiler-Joseph S., Habermann B., Wilm M., Parton R.G., Zerial M. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 2004, 116:445-456.
21. Moller A., Strange P., Gundersen H.J. Efficient estimation of cell volume and number using the nucleator and the disector. J. Microsc. 1990, 159:61-71.
22. Mori F., Tanji K., Zhang H.X., Nishihira Y., Tan C.F., Takahashi H., Wakabayashi K. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008, 116:193-203.
23. Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009, 117:137-149.
24. Nixon R.A., Cataldo A.M. The endosomal-lysosomal system of neurons: new roles. Trends Neurosci. 1995, 18:489-496.
25. Nixon R.A., Yang D.S., Lee J.H. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 2008, 4:590-599.
26. Nonaka T., Arai T., Buratti E., Baralle F.E., Akiyama H., Hasegawa M. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett. 2009, 583:394-400.
27. Pan T., Kondo S., Le W., Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008, 131:1969-1978.
28. Pilecka I., Banach-Orlowska M., Miaczynska M. Nuclear functions of endocytic proteins. Eur. J. Cell Biol. 2007, 86:533-547.
29. Qiao L., Hamamichi S., Caldwell K.A., Caldwell G.A., Yacoubian T.A., Wilson S., Xie Z.L., Speake L.D., Parks R., Crabtree D., Liang Q., Crimmins S., Schneider L., Uchiyama Y., Iwatsubo T., Zhou Y., Peng L., Lu Y., Standaert D.G., Walls K.C., Shacka J.J., Roth K.A., Zhang J. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol. Brain 2008, 1:17.
30. Rink J., Ghigo E., Kalaidzidis Y., Zerial M. Rab conversion as a mechanism of progression from early to late endosomes. Cell 2005, 122:735-749.
31. Sanelli T., Xiao S., Horne P., Bilbao J., Zinman L., Robertson J. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007, 66:1147-1153.
32. Seachrist J.L., Ferguson S.S. Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci. 2003, 74:225-235.
33. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
34. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 2009, 10:513-525.
35. Thorpe J.R., Tang H., Atherton J., Cairns N.J. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy. J. Neural Transm. 2008, 115:1661-1671.
36. Urushitani, M., Sato, T., Bamba, H., Hisa, Y., Tooyama, I., 2010. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J. Neurosci. Res. 88, 784-797.
37. Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18809-18814.
38. Zaidi N., Maurer A., Nieke S., Kalbacher H. Cathepsin D: a cellular roadmap. Biochem. Biophys. Res. Commun. 2008, 376:5-9.
39. Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.L., Tong J., Castanedes-Casey M., Ash P., Gass J., Rangachari V., Buratti E., Baralle F., Golde T.E., Dickson D.W., Petrucelli L. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7607-7612.